Literature DB >> 19756512

Improved detection of blood stream pathogens by real-time PCR in severe sepsis.

Lutz Eric Lehmann1, Klaus-Peter Hunfeld, Martina Steinbrucker, Volker Brade, Malte Book, Harald Seifert, Tobias Bingold, Andreas Hoeft, Heimo Wissing, Frank Stüber.   

Abstract

OBJECTIVE: Evaluation of the technical and diagnostic feasibility of commercial multiplex real-time polymerase chain reaction (PCR) for detection of blood stream infections in a cohort of intensive care unit (ICU) patients with severe sepsis, performed in addition to conventional blood cultures.
DESIGN: Dual-center cohort study.
SETTING: Surgical ICU of two university hospitals. PATIENTS AND PARTICIPANTS: One hundred eight critically ill patients fulfilling the American College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM) severe sepsis criteria were included.
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: PCR results obtained in 453 blood samples from 108 patients were compared with corresponding blood culture results. PCR resulted in a twofold higher positivity rate when compared with conventional blood culture (BC) testing (114 versus 58 positive samples). In 40 out of 58 PCR positive assays the results of the corresponding blood cultures were identical to microorganisms detected by PCR. In 18 samples PCR and BC yielded discrepant results. Compared with conventional blood culture the sensitivity and specificity of PCR was 0.69 and 0.81, respectively. Further evaluation of PCR results against a constructed gold standard including conventional microbiological test results from other significant patient specimen (such as bronchio-alveolar lavage fluid, urine, swabs) and additionally generated clinical and laboratory information yielded sensitivity of 0.83 and specificity of 0.93.
CONCLUSIONS: Our cohort study demonstrates improved pathogen detection using PCR findings in addition to conventional blood culture testing. PCR testing provides increased sensitivity of blood stream infection. Studies addressing utility including therapeutic decision-making, outcome, and cost-benefit following diagnostic application of PCR tests are needed to further assess its value in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756512     DOI: 10.1007/s00134-009-1608-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  28 in total

1.  The emerging power of molecular diagnostics: towards improved management of life-threatening infection.

Authors:  M J Struelens; R de Mendonça
Journal:  Intensive Care Med       Date:  2001-10-30       Impact factor: 17.440

2.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

3.  Studies on the bacteremia of bacterial endocarditis.

Authors:  A S Werner; C G Cobbs; D Kaye; E W Hook
Journal:  JAMA       Date:  1967-10-16       Impact factor: 56.272

Review 4.  Does antibiotic selection impact patient outcome?

Authors:  Stephan Harbarth; Vandack Nobre; Didier Pittet
Journal:  Clin Infect Dis       Date:  2006-11-27       Impact factor: 9.079

5.  The use of polymerase chain reaction to detect septicemia in critically ill patients.

Authors:  R T Cursons; E Jeyerajah; J W Sleigh
Journal:  Crit Care Med       Date:  1999-05       Impact factor: 7.598

Review 6.  Laboratory diagnosis of bacteremia and fungemia.

Authors:  R R Magadia; M P Weinstein
Journal:  Infect Dis Clin North Am       Date:  2001-12       Impact factor: 5.982

7.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

Review 8.  Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients.

Authors:  B E Kreger; D E Craven; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

9.  Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia.

Authors:  Richard F Louie; Zuping Tang; Timothy E Albertson; Stuart Cohen; Nam K Tran; Gerald J Kost
Journal:  Crit Care Med       Date:  2008-05       Impact factor: 7.598

10.  The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study.

Authors:  Fang Gao; Teresa Melody; Darren F Daniels; Simon Giles; Samantha Fox
Journal:  Crit Care       Date:  2005-11-11       Impact factor: 9.097

View more
  30 in total

1.  Diagnostic performance of a multiple real-time PCR assay in patients with suspected sepsis hospitalized in an internal medicine ward.

Authors:  Leonella Pasqualini; Antonella Mencacci; Christian Leli; Paolo Montagna; Angela Cardaccia; Elio Cenci; Ines Montecarlo; Matteo Pirro; Francesco di Filippo; Emma Cistaro; Giuseppe Schillaci; Francesco Bistoni; Elmo Mannarino
Journal:  J Clin Microbiol       Date:  2012-02-08       Impact factor: 5.948

2.  The diagnostic future for bloodstream infections?

Authors:  Paul Philip Dean; Paul Dark
Journal:  Intensive Care Med       Date:  2010-10-28       Impact factor: 17.440

3.  The potential for PCR based testing to improve diagnosis and treatment of sepsis.

Authors:  Ngan Lyle; John Boyd
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

4.  Diagnostic performance and therapeutic impact of LightCycler SeptiFast assay in patients with suspected sepsis.

Authors:  V Herne; A Nelovkov; M Kütt; M Ivanova
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-03-13

5.  Blood cultures at central line insertion in the intensive care unit: comparison with peripheral venipuncture.

Authors:  Sheldon Stohl; Shmuel Benenson; Sigal Sviri; Alexander Avidan; Colin Block; Charles L Sprung; Phillip D Levin
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

Review 6.  Accuracy of LightCycler(®) SeptiFast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a systematic review and meta-analysis.

Authors:  Paul Dark; Bronagh Blackwood; Simon Gates; Danny McAuley; Gavin D Perkins; Ronan McMullan; Claire Wilson; Daniel Graham; Kate Timms; Geoffrey Warhurst
Journal:  Intensive Care Med       Date:  2014-11-22       Impact factor: 17.440

7.  Molecular diagnosis of sepsis: New aspects and recent developments.

Authors:  O Liesenfeld; L Lehman; K-P Hunfeld; G Kost
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

8.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kit.

Authors:  Katsunori Yanagihara; Yuko Kitagawa; Masao Tomonaga; Kunihiro Tsukasaki; Shigeru Kohno; Masafumi Seki; Hisashi Sugimoto; Takeshi Shimazu; Osamu Tasaki; Asako Matsushima; Yasuo Ikeda; Shinichiro Okamoto; Naoki Aikawa; Shingo Hori; Hideaki Obara; Akitoshi Ishizaka; Naoki Hasegawa; Junzo Takeda; Shimeru Kamihira; Kazuyuki Sugahara; Seishi Asari; Mitsuru Murata; Yoshio Kobayashi; Hiroyuki Ginba; Yoshinobu Sumiyama; Masaki Kitajima
Journal:  Crit Care       Date:  2010-08-24       Impact factor: 9.097

10.  Syndrome Evaluation System (SES) versus Blood Culture (BACTEC) in the Diagnosis and Management of Neonatal Sepsis--A Randomized Controlled Trial.

Authors:  B Vishnu Bhat; P Prasad; Venkata Banda Ravi Kumar; B N Harish; K Krishnakumari; Anand Rekha; G Manjunath; B Adhisivam; B Shruthi
Journal:  Indian J Pediatr       Date:  2016-01-06       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.